Search results
Collegium Pharmaceutical (COLL) Q1 Earnings and Revenues Lag Estimates
Zacks via Yahoo Finance· 5 hours agoCollegium Pharmaceutical (COLL) delivered earnings and revenue surprises of -2.68% and 1.44%,...
Marinus Pharmaceuticals lays off 20% of its workforce in cost-cutting move - Philadelphia Business...
The Business Journals· 1 day agoThe Radnor pharmaceutical company, which listed 165 employees as of the end of 2023, said Wednesday...
Earnings call: Syndax Pharmaceuticals outlines robust Q1 2024 performance By Investing.com
Investing.com· 9 hours agoSyndax Pharmaceuticals , Inc. (NASDAQ: NASDAQ:SNDX) has efficiently executed its corporate strategy...
Formosa Pharmaceuticals Announces Licensing Agreement with Tabuk Pharmaceuticals, for...
WRBL Columbus· 20 hours agoFood and Drug Administration (FDA) on March 4, 2024.
5 weight-loss drug stocks to watch as Ozempic, Zepbound sales surge
Bankrate via AOL· 1 day agocompany also reported sales growth of 36 percent in 2023. Novo’s market value is now greater than...
Vermont Senator Peter Welch criticizes growing profits for pharmaceutical companies outlined in new...
WAMC Northeast Public Radio· 9 hours agoFollowing a report issued Tuesday showing record profits from drug companies, Vermont Senator Peter Welch and Michigan Congresswoman Debbie Dingell...affordable health care ...
Drugmakers in Medicare Price Talks Spent Less on R&D Than on Shareholders, Marketing, Overhead:...
The Fiscal Times via Yahoo Finance· 4 hours agoEight drug companies that make the 10 medications whose prices are currently being negotiated by...
Earnings call: X4 Pharmaceuticals reports Q1 2024 results and drug developments By Investing.com
Investing.com· 2 days agoX4 Pharmaceuticals (NASDAQ:XFOR) has announced its financial results for the first quarter of 2024...
How Top 7% Earnings Powerhouse Catalyst Pharmaceuticals Just Did It Again
Investor's Business Daily· 7 hours ago"Early Agamree launch indicators highlight promising product uptake, surpassing initial...
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Zacks via Yahoo Finance· 11 hours agoCatalyst Pharmaceuticals, Inc. CPRX reported adjusted earnings of 38 cents per share for the first...